Literature DB >> 18157532

GMP--three letters with many interpretations. Protection of patients or killing the clinical and research applications of PET?

Bengt Långström, Per Hartvig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18157532     DOI： 10.1007/s00259-007-0657-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  2 in total

1.  The specific case of radiopharmaceuticals and GMP--activities of the Radiopharmacy Committee.

Authors:  C Decristoforo; P Elsinga; A Faivre-Chauvet; B Farstad; G Meyer; R Mikolajczak; I Penuelas; P Unak; G Westera
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-15       Impact factor: 9.236

Review 2.  18F-labelled intermediates for radiosynthesis by modular build-up reactions: newer developments.

Authors:  Johannes Ermert
Journal:  Biomed Res Int       Date:  2014-06-23       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.